Aspen Pharmacare Current Ratio 2017-2024 | APNHY

Aspen Pharmacare current ratio from 2017 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aspen Pharmacare Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-12-31 $2.26B $0.96B 2.35
2024-06-30 $2.36B $1.30B 1.81
2023-12-31 $2.35B $1.23B 1.92
2023-06-30 $2.51B $1.31B 1.92
2022-12-31 $2.25B $0.94B 2.40
2022-06-30 $2.27B $1.54B 1.48
2021-12-31 $2.37B $1.21B 1.96
2021-06-30 $2.13B $2.40B 0.89
2020-12-31 $2.79B $1.29B 2.16
2020-06-30 $2.37B $1.16B 2.03
2019-06-30 $2.55B $1.41B 1.80
2018-12-31 $3.17B $1.55B 2.05
2018-06-30 $3.14B $2.20B 1.43
2017-12-31 $2.65B $2.97B 0.89
2017-06-30 $2.80B $2.56B 1.10
2016-12-31 $2.61B $1.76B 1.48
2016-06-30 $2.58B $1.46B 1.76
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $2.392B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $18.420B 6.58
Dr Reddy's Laboratories (RDY) India $12.089B 21.94
BridgeBio Pharma (BBIO) United States $8.831B 0.00
Bausch Health Cos (BHC) Canada $2.335B 1.68
Supernus Pharmaceuticals (SUPN) United States $1.811B 14.70
Amphastar Pharmaceuticals (AMPH) United States $0.972B 6.53
Taysha Gene Therapies (TSHA) United States $0.552B 0.00
Personalis (PSNL) United States $0.547B 0.00
Assembly Biosciences (ASMB) United States $0.143B 0.00
Sol-Gel Technologies (SLGL) Israel $0.023B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00